{
  "docId": "019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "docSlug": "6ded4b1cfe2c",
  "documentTitle": "Bristol-Myers Squibb Company (BMY)",
  "authorId": "03_Starboard_Value",
  "authorName": "Starboard Value",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2019-03-18 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 67,
  "pageCount": 197,
  "prevPage": 66,
  "nextPage": 68,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 10,
  "notes": "The slide uses a combination of a quote/excerpt and a data table to build a case against the company's business practices.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "screenshot",
    "data_table",
    "callout_box"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622b-71dc-a6d9-fc4318e06f9b/67",
  "deckHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b",
  "deckJsonHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b.json",
  "deckAnchorHref": "/decks/019dd923-622b-71dc-a6d9-fc4318e06f9b#slide-67",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.45
      },
      "kind": "callout",
      "text": "Sen. Richard Blumenthal Accusing Celgene of Anticompetitive Behavior",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11055121-8014-4e88-b564-d880cbcc58b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.51,
        "y": 0.45
      },
      "kind": "callout",
      "text": "FDA List of Pharmaceutical Companies Receiving the Most Complaints for Anti-Competitive Behavior",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adddcc84-96a7-4999-9075-e1a847cc0f1f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "list",
      "text": "To prevent drug genericization, Celgene and others have used aggressive interpretations of FDA regulations to block generic drug manufacturers from gaining access to their drug samples; these drug samples are required for generic manufacturers to prove bioequivalence, a key test to gain FDA approval for generic products.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "262fe5e5-9dc4-4711-a8ff-ba8dfdd8d9c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.36
      },
      "kind": "list",
      "text": "In an effort to shame pharmaceutical companies that block generic manufacturers from accessing their drugs, the FDA publishes a list of pharmaceutical companies that receive the most complaints for anti-competitive behavior – Celgene tops the list.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "457fb2c8-4a1c-4ad3-ac09-6d0695db26e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Separately, in June 2018, Sen. Richard Blumenthal sent a letter to the Federal Trade Commission (“FTC”) alleging that pharmaceutical companies, in particular Celgene, are engaging in anti-competitive behavior to prevent drug genericization (excerpt from letter below).",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "deaa4084-6c14-41a4-80c6-c5c1073ec0b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.04,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: U.S. Government public documents, U.S. Food & Drug Administration.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4b5a4807-9f9c-4368-833e-cde69ef82109",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.51,
        "y": 0.52
      },
      "kind": "table",
      "text": "Company: Celgene Corp, # of Drugs: 3, # of Complaints: 31; Actelion: 4, 26; Gilead: 2, 11; Novartis: 4, 11; Lundbeck: 2, 8",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33d145ca-dae9-45f8-903b-b88c35f5a92d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.92,
        "x": 0.04,
        "y": 0.85
      },
      "kind": "title",
      "text": "Celgene has been called out as “anti-competitive” by a member of the U.S. Senate",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c45cc88a-74f0-46fd-b147-d8a9ec522a91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.11,
        "w": 0.92,
        "x": 0.04,
        "y": 0.03
      },
      "kind": "title",
      "text": "In Addition, Celgene’s Anti-Competitive Behavior Has Also Caught the Government’s Attention",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b803aa22-05fb-4d71-a93d-c0da61ab62d6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "d471036b-bc4d-4e73-be8f-f7fbd276b4d0",
      "evidence": "The slide frames Celgene as the antagonist by highlighting government complaints and anti-competitive behavior.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}